• Daily Marijuana Observer Facebook
  • Daily Marijuana Observer Twitter
  • Daily Marijuana Observer StockTwits
  • Daily Marijuana Observer SA
  • Daily Marijuana Observer Instagram
  • Daily Marijuana Observer Youtube
  • Pinterest Social Icon
  • Daily Marijuana Observer Talk Market

Connecticut: Proposal to Waive MMP Fees for Veterans Gets Public Hearing

February 23, 2018

 (Photo Credit - Nick Youngson)


Veterans who qualify for Connecticut’s medical marijuana program might soon find the cost of their state fees waived under recently proposed legislation.


Senate Bill No. 225, also referred to as “An Act Waiving for Veterans Certain Fees for Prescribed Medical Marijuana,” would require Connecticut’s Commissioner of Consumer Protection to waive the registration and administration fees for veterans who qualify as patients under the state’s guidelines.


At 1 p.m. on Feb. 27, the Veterans Affairs Committee will hold a public hearing in Room 1C of the Legislative Office Building. Sign-up for the hearing will begin at noon in the First Floor Atrium.


S.B. 225 would repeal and replace specific verbiage within Sec. 21a-408D and require the Commissioner of Consumer Protection to waive the registration and administration fees for veterans registered as qualifying patients for the palliative use of marijuana.


Per S.B. 225: “No such fee shall be charged to a qualifying patient who is a veteran, as defined in subsection (a) of section 27-103.”


Those wishing to participate in the public hearing will need to submit 25 copies of their written statement to the Committee’s staff ahead of the Feb. 27 hearing.


The first hour of the public hearing is reserved for legislators, constitutional officers, state agency heads and chief elected municipal officials. Public speakers will be limited to three minutes of testimony. The Committee encourages witnesses to submit their written statement and condense their oral testimony to a summary of that statement. SB 225 is the third item on the agenda.


The U.S. Department of Veterans Affairs noted on their website that a review of existing scientific data indicates medicinal cannabis provides therapeutic relief for neuropathic pain and could mitigate spasticity associated with MS – but not post-traumatic stress disorder.


 This article was originally published on Marijuana.com


About Monterey Bud: Born in Long Beach, raised on the central coast: I surf, dab, burn, and blog – though not necessarily in that order. I'm a husband, a father and a lifelong consumer of connoisseur grade weed. I don't drink alcohol or consume any other "drugs." I consider myself to be living proof that weed is not a gateway drug. If it were, I'd be in some serious trouble. Instead, as a 50-year-old ex-realtor that has been smoking weed for nearly 80% of my life (just did the math) ... I can only say, marijuana is safer than prescription pills or alcohol could ever hope to be for calming what stirs the savage beast.

Please reload

Please reload

Please reload


© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.